(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Health officials report 14 Legionnaires' disease cases in Florida, gym connection suspected - 2The Best Internet based Courses for Expertise Improvement
- 3Ice Spice's 'Big Guy' SpongeBob song is stuck in everyone's heads again — and TikTok is fueling it
- 4The Electric Bicycle Americans Can Confide in 2024
- 5Is new Harry Styles music on the way? Fans think so, after a cryptic website and posters pop up.
- Figure out how to Team up with Your Auto Crash Legal advisor for Best Outcomes
- Viable Correspondence: Building Solid Connections
- Figure out How to Augment the Advantages of a Web-based Degree
- Mexico says a third of 130,000 missing people might be alive, fueling criticisms by families
- Motivational Travel Objections for History Buffs
- The Ascent of the Kona SUV: How Hyundai's Reduced Hybrid Is Vanquishing the Streets
- A definitive Manual for the 5 Off-road Bicycles Available
- Russian billionaire says 12-hour days and 6-day workweeks could help save the economy
- Nvidia Share Price Could Be Hit Hard By Iran War
